About
AI Drug Development
Areas of Focus
Categories
AI Focused
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
28
By Phase
PHASE1/PHASE2: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06631092Lead Sponsor
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
PHASE1/PHASE2Recruiting
8 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2028
NCT06631079Lead Sponsor
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors
PHASE1/PHASE2Recruiting
20 participants
Started: Oct 7, 2024 · Completed: Dec 31, 2028
Locations (1)
Headquarters
Mannheim, Germany
Map
Loading map...